| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/17/2008 | US7388002 Nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases |
| 06/17/2008 | US7388001 Halide-free glucosamine sulfate compositions and methods of preparation |
| 06/17/2008 | US7388000 Halide-free glucosamine phosphate compositions and methods of preparation |
| 06/17/2008 | US7387999 Simmondsin for use as angiogenesis inhibitor |
| 06/17/2008 | US7387994 Antitumor, anticancer agents; particles or coils or stents coated solid-phase agent comprising a binding agent comprising collagen are directed to target vasculature, such as the vasculature of solid tumor masses or aneurysms |
| 06/17/2008 | US7387810 Method of forming rate limiting barriers for implantable devices |
| 06/17/2008 | US7387807 Topical composition comprising feverfew |
| 06/17/2008 | US7387806 Method of using geranium oil and sophora root extracts as a supporting composition in cancer treatments |
| 06/17/2008 | US7387803 Dietary fiber delivery system |
| 06/17/2008 | US7387800 Mixture containing plant extract; renin, angiogenesis inhibitor; cardiovascular disorders; antidiabetic agents; liver disorders; gall stones; gastrointestinal disorders |
| 06/17/2008 | US7387799 Mixture of catalytic metal compound, coenzyme, reducing agents or oxidizer and adjuvant; applying as aerosol, or film to medical equipment, filters, air conditioner |
| 06/17/2008 | US7387798 Method and composition for resuscitation |
| 06/17/2008 | US7387796 Stable compositions of S-adenosyl-l-methionine with dextran |
| 06/17/2008 | US7387793 Such as capsules/beads of cyclobenzaprine hydrochloride |
| 06/17/2008 | US7387791 Oral administering; tablet with enteric coating; supplying drug to gastrointestinal systems |
| 06/17/2008 | US7387790 Non-gas containing nanoparticles comprising a mixture of select lipids capable of being internalized within a targeted tissue or cell sufficient to achieve a desired effect; anticancer agents |
| 06/17/2008 | US7387789 Transdermal delivery of non-steroidal anti-inflammatory drugs |
| 06/17/2008 | US7387788 Analgesic, Parkinson or Alzheimer drug in a solvent system containing a monoalkyl ether of diethylene glycol, a glycol, and a mixture of a C2 to C4 alcohol and water; inhibits crystallization and transfer to clothing, improves and modulates bioavailability within skin layers; nonocclusive, semi-solid |
| 06/17/2008 | US7387786 Food additive compositions containing sterol esters, solubilizing agents, dispersants and antioxidants |
| 06/17/2008 | US7387783 For cleaning skin; cosmetics |
| 06/17/2008 | US7387771 dissolving in carrier liquid; drug linked to a protein-binding molecule via a spacer which is cleaved hydrolytically or enzymatically in the body of a subject in a pH-dependent manner; tissue targeted delivery; Doxorubicin-phenylacetylhydrazone spacer-maleimide |
| 06/17/2008 | US7387271 Immunostimulatory combinations |
| 06/17/2008 | CA2501799C Pyrazole compounds for treatment of neurodegenerative disorders |
| 06/17/2008 | CA2467356C Selective norepinephrine serotonin reuptake inhibitors for treating fibromyalgia syndrome, chronic fatigue syndrome and pain |
| 06/17/2008 | CA2451990C A new compound for the treatment of impotence |
| 06/17/2008 | CA2444053C Fused bicyclic or tricyclic amino acids |
| 06/17/2008 | CA2439904C Immobilizing objects in the body |
| 06/17/2008 | CA2439152C Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 06/17/2008 | CA2414063C Highly concentrated stable meloxicam solutions |
| 06/17/2008 | CA2395193C Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 06/17/2008 | CA2393749C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 06/17/2008 | CA2391076C Solutions containing epinastin |
| 06/17/2008 | CA2384188C Antiviral compositions |
| 06/17/2008 | CA2383114C Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions |
| 06/17/2008 | CA2369947C Hydroxamic acid derivative |
| 06/17/2008 | CA2367704C Pyrazolobenzodiazepines as cdk2 inhibitors |
| 06/17/2008 | CA2358313C Food or veterinary composition for domestic carnivores containing free tyrosine |
| 06/17/2008 | CA2356380C Immunosuppressive effects of pteridine derivatives |
| 06/17/2008 | CA2350220C Antioxidant composition comprising propionyl l-carnitine and a flavonoid against thrombosis and atherosclerosis |
| 06/17/2008 | CA2331737C Agents for relieving side effects caused by use of an anti-tumour agent |
| 06/17/2008 | CA2331076C Stable carbanilide composition |
| 06/17/2008 | CA2330798C Febrifugine, isofebrifugine and method for producing the same |
| 06/17/2008 | CA2314112C A method for making a pharmaceutical formulation |
| 06/17/2008 | CA2309963C 6-o-alkyl erythromycin b oxime |
| 06/17/2008 | CA2309202C Adenosine a1 receptor agonists |
| 06/17/2008 | CA2303884C Inorganic-polymer complexes for the controlled release of compounds including medicinals |
| 06/17/2008 | CA2302347C 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-oles, processes for their preparation and their use for medicaments |
| 06/17/2008 | CA2294457C Pharmaceutical composition for application to mucosa |
| 06/17/2008 | CA2286772C Fungicide active substance combinations |
| 06/17/2008 | CA2284732C Analogs of cocaine |
| 06/17/2008 | CA2284468C Anti-inflammatory compounds |
| 06/17/2008 | CA2281562C Forskolin for promoting lean body mass |
| 06/17/2008 | CA2279788C Cation exchange resin preparation |
| 06/17/2008 | CA2272291C Crf antagonistic quino- and quinazolines |
| 06/17/2008 | CA2264118C Tetrahydroquinoline derivatives as eaa antagonists |
| 06/17/2008 | CA2261762C Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing tnf-alpha levels |
| 06/17/2008 | CA2255062C Process of purification of cyclosporin |
| 06/17/2008 | CA2253113C Carbohydrate derivatives |
| 06/17/2008 | CA2251886C An oral pharmaceutical formulation containing ibandronate |
| 06/17/2008 | CA2249446C Irreversible inhibitors of tyrosine kinases |
| 06/17/2008 | CA2247336C Parapoxviruses containing foreign dna, their production and their use in vaccines |
| 06/17/2008 | CA2224269C Compressed dry-granulation desogestrel tablets |
| 06/17/2008 | CA2202487C Fused pyrrolocarbazoles |
| 06/17/2008 | CA2200589C Emulsifiable composition for the control of insects |
| 06/17/2008 | CA2200189C Scopolamine plaster |
| 06/17/2008 | CA2188892C Use of an yttrium salt in a compound for the treatment of sensitive skin |
| 06/17/2008 | CA2187162C Dna encoding precursor of interleukin-1.beta. converting enzyme-related cysteine proteinase iii (icerel iii) |
| 06/17/2008 | CA2166388C Antifungal composition for external use retentive in stratum corneum |
| 06/17/2008 | CA2163361C Therapeutic substituted guanidines |
| 06/17/2008 | CA2151826C Pharmaceutical compositions for prevention and treatment of cancerous diseases and process for their preparation |
| 06/17/2008 | CA2146954C Breath activated nicotine inhalers |
| 06/17/2008 | CA2100394C Cosmetic sunscreen |
| 06/17/2008 | CA2067250C Inhibition of padgem-mediated cell binding |
| 06/12/2008 | WO2008085797A2 miR-16 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
| 06/12/2008 | WO2008070875A2 Polyhydroquinoline compounds and dihydropyridine compounds for inhibiting beta-amyloid production |
| 06/12/2008 | WO2008070831A2 Bisbenzamidines and bisbenzamidoximes for the treatment of human african trypanosomiasis |
| 06/12/2008 | WO2008070783A2 Compositions and methods comprising zingiber species |
| 06/12/2008 | WO2008070778A2 Pyridoxamine and low molecular weight heparinoids for diabetic kidney disease |
| 06/12/2008 | WO2008070758A1 Chemokine receptor binding compounds |
| 06/12/2008 | WO2008070741A1 Compositions and methods for enhancing survival and reducing injury under ischemic or hypoxic conditions |
| 06/12/2008 | WO2008070740A1 Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| 06/12/2008 | WO2008070739A1 Ksp activators |
| 06/12/2008 | WO2008070733A2 Macrocyclic hepatitis c serine protease inhibitors and uses therefor |
| 06/12/2008 | WO2008070728A2 Treatment for dry eye using testosterone and progestagen |
| 06/12/2008 | WO2008070726A2 Treatment for dry eye |
| 06/12/2008 | WO2008070707A1 Il-8 receptor antagonists |
| 06/12/2008 | WO2008070670A2 Enhanced immediate release formulations of topiramate |
| 06/12/2008 | WO2008070661A1 Substituted pyrimidines as adenosine receptor antagonists |
| 06/12/2008 | WO2008070640A1 Imidated biopolymer adhesive and hydrogel |
| 06/12/2008 | WO2008070619A1 Deuterated oxazolidinones and their use as antibiotics |
| 06/12/2008 | WO2008070609A1 Thienyl-containing glycopyranosyl derivatives as antidiabetics |
| 06/12/2008 | WO2008070599A1 Indazole compounds |
| 06/12/2008 | WO2008070583A2 Thrombopoietin mimetics |
| 06/12/2008 | WO2008070552A2 Inhibitors of protein tyrosine phosphatase for the promotion of physiological cardiac hypertrophy |
| 06/12/2008 | WO2008070547A1 Improved acyclovir formulations |
| 06/12/2008 | WO2008070529A2 A2a adenosine receptor antagonists |
| 06/12/2008 | WO2008070490A2 Fluoropolymer-based emulsions for the intravenous delivery of fluorinated volatile anesthetics |
| 06/12/2008 | WO2008070463A2 Endoxifen methods and compositions |
| 06/12/2008 | WO2008070462A2 N-oxides of 4,5-epoxy-morphinanium analogs |
| 06/12/2008 | WO2008070402A2 Intraocular drug delivery systems |